Effect of difference between EV-A71 virus epidemic strain and “vaccine strain” on neutralizing antibody titer

References

• Ishimaru Y, Nakano S, Yamaoka K, Takami S. Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system[J]. Arch Dis Child. 1980;55:1–10.
   PubMed Web of Science ®Google Scholar
• Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71[J]. Lancet Infect Dis. 2010;10:778–790.
   PubMed Web of Science ®Google Scholar
• Chan LG, Parashar UD, Lye MS, Ong FGL, Zaki SR, Alexander JP, Ho KK, Han LL, Pallansch MA, Suleiman AB, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. For the outbreak study group[J]. Clin Infect Dis. 2000;31(3):678–683.
   PubMed Web of Science ®Google Scholar
• McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance[J]. FEMS Microbiol Rev. 2002;26:91–107.
   PubMed Web of Science ®Google Scholar
• Qiu J. Enterovirus 71 infection: a new threat to global public health?[J]. Lancet Neurol. 2008;7:868–869.
   PubMed Web of Science ®Google Scholar
• Xu J, Qian Y, Wang S, Serrano JMG, Li W, Huang Z, Lu S. EV71: an emerging infectious disease vaccine target in the far East?[J]. Vaccine. 2010;28:3516–3521.
   PubMed Web of Science ®Google Scholar
• Van Tu P, Thao N, Perera D, Truong KH, Tien NTK, Thuong TC, How OM, Cardosa MJ, McMinn PC. Epidemiologic and virologic investigation of hand, foot, and mouth disease, Southern Vietnam, 2005[J]. Emerg Infect Dis. 2007;13:1733–1741.
   PubMed Web of Science ®Google Scholar
• Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, Zhang Y, Li Y, Mao Q, Wang J, et al. An inactivated enterovirus 71 vaccine in healthy children[J]. N Engl J Med. 2014;370(9):829–837.
   PubMed Web of Science ®Google Scholar
• van der Sanden S, Koopmans M, Uslu G, van der Avoort H. Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008[J]. J Clin Microbiol. 2009;47:2826–2833.
   PubMed Web of Science ®Google Scholar
• Chang P, Chen S, Chen K, The Current Status of the Disease Caused by Enterovirus 71 Infections: Epidemiology, Pathogenesis, Molecular Epidemiology, and Vaccine Development[J]. IJERPH.2016;13(9):890.
   Google Scholar
• Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, Mao N, Xu S, Zhu S, Cui A, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China[J]. Virol J. 2010;7(1):94.
   PubMedGoogle Scholar
• Li JX, Mao QY, Liang ZL, Ji H, Zhu F-C. Development of enterovirus 71 vaccines: from the lab bench to phase III clinical trials[J]. Expert Rev Vaccines. 2014;13:609–618.
   PubMed Web of Science ®Google Scholar
• Mao QY, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of Hand, Foot and Mouth Disease (HFMD)[J]. Expert Rev Vaccines. 2016;15:599–606.
   PubMed Web of Science ®Google Scholar
• Yamazaki K, Okuno Y. Genetic diagnosis and molecular epidemiological analyses of hand, foot and mouth disease which prevailed in osaka prefecture in 2000][J]. Kansenshogaku Zasshi. 2001;75:909–915.
   PubMedGoogle Scholar
• Ooi EE, Phoon MC, Ishak B, Chan S-H. Seroepidemiology of human enterovirus 71, Singapore[J]. Emerg Infect Dis. 2002;8:995–997.
   PubMed Web of Science ®Google Scholar
• Li W, Yi L, Su J, Lu J, Ke C, Zeng H, Guan D, Ma C, Zhang W, Xiao H, et al. Seroprevalence of human enterovirus 71 and coxsackievirus A16 in Guangdong, China, in pre- and post-2010 HFMD epidemic period[J]. PLoS One. 2013;8(12):e80515.
   PubMed Web of Science ®Google Scholar
• Zeng M, El KN, Tu S, Ren P, Xu S, Zhu Q, Mo X, Pu D, Wang X, Altmeyer R, et al. Seroepidemiology of enterovirus 71 infection prior to the 2011 season in children in Shanghai[J]. J Clin Virol. 2012;53(4):285–289.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhu S, Guo X, Wang J, Wang D, Yan D, Tan X, Tang L, Zhu H, Yang Z, et al. Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008[J]. Virol J. 2010;7(1):300.
   PubMedGoogle Scholar
• Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, Chang Z, Liu F, Fang VJ, Zheng Y, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study[J]. Lancet Infect Dis. 2014;14(4):308–318.
   PubMed Web of Science ®Google Scholar
• Li T, Wang H, Lu Y, Li Q, Chen C, Wang D, Li M, Li Y, Lu J, Chen Z, et al. Willingness and influential factors of parents to vaccinate their children with novel inactivated enterovirus 71 vaccines in Guangzhou, China[J]. Vaccine. 2018;36(26):3772–3778.
   PubMed Web of Science ®Google Scholar
• Huang SW, Cheng HL, Hsieh HY, Chang C-L, Tsai H-P, Kuo P-H, Wang S-M, Liu C-C, Su I-J, Wang J-R, et al. Mutations in the non-structural protein region contribute to intra-genotypic evolution of enterovirus 71[J]. J Biomed Sci. 2014;21(1):33.
   PubMedGoogle Scholar
• Hu Y, Zeng G, Chu K, Zhang J, Han W, Zhang Y, Li J, Zhu F. Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: a further observation[J]. Hum Vaccin Immunother. 2018;14(6):1517–1523.
   PubMed Web of Science ®Google Scholar
• Zhang W, Kong Y, Jiang Z, Li C, Wang L, Xia J. Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trial[J]. Hum Vaccin Immunother. 2016;12(4):922–930.
   PubMed Web of Science ®Google Scholar
• Huang SW, Hsu YW, Smith DJ, Kiang D, Tsai HP, Lin KH, Wang SM, Liu CC, Su IJ, Wang JR. Reemergence of enterovirus 71 in 2008 in Taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008[J]. J Clin Microbiol. 2009;47(11):3653–3662.
   PubMed Web of Science ®Google Scholar
• Noisumdaeng P, Sangsiriwut K, Prasertsopon J, Klinmalai C, Payungporn S, Mungaomklang A, Chokephaibulkit K, Buathong R, Thitithanyanont A, Puthavathana P. Complete genome analysis demonstrates multiple introductions of enterovirus 71 and coxsackievirus A16 recombinant strains into Thailand during the past decade[J]. Emerg Microbes Infect. 2018;7(1):214.
   PubMedGoogle Scholar
• Martcheva M, Bolker BM, Holt RD. Vaccine-induced pathogen strain replacement: what are the mechanisms?[J]. J R Soc Interface. 2008;5:3–13.
   PubMed Web of Science ®Google Scholar
• Ooi MH, Wong SC, Podin Y, Akin W, Del Sel S, Mohan A, Chieng CH, Perera D, Clear D, Wong D, et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study[J]. Clin Infect Dis. 2007;44(5):646–656.
   PubMed Web of Science ®Google Scholar
• Premanand B, Kiener TK, Meng T, Tan YR, Jia Q, Chow VT, Kwang J. Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1[J]. Antiviral Res. 2012;95(3):311–315.
   PubMed Web of Science ®Google Scholar
• Le TV, Nguyen VT, Nguyen QH, Pham DT. Molecular epidemiology analysis of enterovirus 71 strains isolated in Dak Lak, Vietnam, 2011-2016[J]. J Med Virol. 2019;91(1):56–64.
   PubMed Web of Science ®Google Scholar
• van der Sanden S, van der Avoort H, Lemey P, Uslu G, Koopmans M. Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses[J]. J Gen Virol. 2010;91(Pt 8):1949–1958.
   PubMedGoogle Scholar
• Chang J, Li J, Wei W, Liu X, Liu G, Yang J, Zhang W, Yu XF. Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model[J]. Immunol Res. 2015;62(3):306–315.
   PubMed Web of Science ®Google Scholar
• Li L, He Y, Yang H, Zhu J, Xu X, Dong J, Zhu Y, Jin Q. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, people’s republic of China[J]. J Clin Microbiol. 2005;43(8):3835–3839.
   PubMed Web of Science ®Google Scholar
• Hanna-Wakim R, Yasukawa LL, Sung P, Arvin AM, Gans HA. Immune responses to mumps vaccine in adults who were vaccinated in childhood[J]. J Infect Dis. 2008;197(12):1669–1675.
   PubMed Web of Science ®Google Scholar
• Desselberger U, Huppertz HI. Immune responses to rotavirus infection and vaccination and associated correlates of protection[J]. J Infect Dis. 2011;203:188–195.
   PubMed Web of Science ®Google Scholar
• Yip CC, Lau SK, Zhou B, Zhang MX, Tsoi HW, Chan KH, Chen XC, Woo PC, Yuen KY. Emergence of enterovirus 71 “double-recombinant” strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71[J]. Arch Virol. 2010;155(9):1413–1424.
   PubMed Web of Science ®Google Scholar
• Domingo E, Wain-Hobson S. The 30th anniversary of quasispecies. Meeting on ‘Quasispecies: past, present and future’[J]. EMBO Rep. 2009;10:444–448.
   PubMed Web of Science ®Google Scholar
• Domingo E, Martin V, Perales C, Escarmis C. Coxsackieviruses and quasispecies theory: evolution of enteroviruses[J]. Curr Top Microbiol Immunol. 2008;323:3–32.
   PubMed Web of Science ®Google Scholar
• Han X, Ying XL, Zhou SL, Han T, Huang H, Jin Q, Yang F, Sun QY, Sun XX. Characterization of the enterovirus 71 P1 polyprotein expressed in pichia pastor as a candidate vaccine[J]. Hum Vaccin Immunother. 2014;10(8):2220–2226.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li C, He D, Cheng T, Ge S, Shih JW, Zhao Q, Chen PJ, Zhang J, Xia N. Antigenic analysis of divergent genotypes human enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity[J]. Vaccine. 2013;31(2):425–430.
   PubMed Web of Science ®Google Scholar
• Liu L, Mo Z, Liang Z, Zhang Y, Li R, Ong KC, Wong KT, Yang E, Che Y, Wang J, et al. Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations[J]. BMC Med. 2015;13:226.
   PubMed Web of Science ®Google Scholar
• Huang KY, Lin JJ, Chiu CH, Yang S, Tsao KC, Huang YC, Lin TY. A potent virus-specific antibody-secreting cell response to acute enterovirus 71 infection in children[J]. J Infect Dis. 2015;212(5):808–817.
   PubMed Web of Science ®Google Scholar
• Lei D, Griffiths E, Martin J. WHO working group meeting to develop WHO recommendations to assure the quality, safety and efficacy of enterovirus 71 vaccines[J]. Vaccine. 2020;38:4917–4923.
   PubMed Web of Science ®Google Scholar
• Anderson CS, McCall PR, Stern HA, Yang H, Topham DJ. Antigenic cartography of H1N1 influenza viruses using sequence-based antigenic distance calculation[J]. BMC Bioinform. 2018;19(1):51.
   PubMed Web of Science ®Google Scholar
• Du X, Dong L, Lan Y, Peng Y, Wu A, Zhang Y, Huang W, Wang D, Wang M, Guo Y, et al. Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation[J]. Nat Commun. 2012;3:709.
   PubMed Web of Science ®Google Scholar
• Lee MS, Chen JS. Predicting antigenic variants of influenza A/H3N2 viruses[J]. Emerg Infect Dis. 2004;10:1385–1390.
   PubMed Web of Science ®Google Scholar
• Lu C, Cai Z, Zou Y, Zhang Z, Chen W, Deng L, Du X, Wu A, Yang L, Wang D, et al. FluPhenotype-a one-stop platform for early warnings of the influenza a virus[J]. Bioinf. 2020;36(10):3251–3253.
   PubMed Web of Science ®Google Scholar
• Luksza M, Lassig M. A predictive fitness model for influenza[J]. Nature. 2014;507:57–61.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Van Tan L, Luo K, Liao Q, Wang L, Qiu Q, Zou G, Liu P, Anh NT, Hong NT, et al. Genetic variation of multiple serotypes of enteroviruses associated with hand, foot and mouth disease in Southern China[J]. Virol Sin. 2021;36(1):61–74.
   PubMed Web of Science ®Google Scholar